Efficacy of Bortezomib Plus Dexamethasone Versus Bortezomib Monotherapy In Patients with Relapsed/Refractory Multiple Myeloma: An Interim Report from an International Electronic Observational Study.

التفاصيل البيبلوغرافية
العنوان: Efficacy of Bortezomib Plus Dexamethasone Versus Bortezomib Monotherapy In Patients with Relapsed/Refractory Multiple Myeloma: An Interim Report from an International Electronic Observational Study.
المؤلفون: Dhawan, Ravinder, Diels, Joris K., van de Velde, Helgi, Spencer, Michael D., Delforge, Michel, Dimopoulos, Meletios A., De Samblanx, Hadewijch M., Roussou, Maria G., Zervas, Konstantinos, Katodritou, Eirini, Sargin, Deniz, Hulin, Cyrille, Ahlberg, Lucia, De La Rubia, Javier, Ganguly, Rita
المساهمون: 137578
سنة النشر: 2021
مصطلحات موضوعية: Sağlık Bilimleri, Dahili Tıp Bilimleri, İç Hastalıkları, Hematoloji, HEMATOLOJİ, Tıp, Klinik Tıp (MED), Klinik Tıp
نوع الوثيقة: report
اللغة: English
العلاقة: Dimopoulos M. A. , De Samblanx H. M. , Roussou M. G. , Zervas K., Katodritou E., Sargin D., Hulin C., Ahlberg L., De La Rubia J., Ganguly R., et al., "Efficacy of Bortezomib Plus Dexamethasone Versus Bortezomib Monotherapy In Patients with Relapsed/Refractory Multiple Myeloma: An Interim Report from an International Electronic Observational Study.", 52nd Annual Meeting of the American-Society-of-Hematology (ASH), Florida, Amerika Birleşik Devletleri, 4 - 07 Aralık 2010, cilt.116, ss.1247-1248; vv_1032021; av_7eb09f26-2a76-4f39-a404-b3f0b98be9a7; http://hdl.handle.net/20.500.12627/86491Test; 116
الإتاحة: https://doi.org/20.500.12627/86491Test
https://hdl.handle.net/20.500.12627/86491Test
رقم الانضمام: edsbas.851DE803
قاعدة البيانات: BASE